ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,565Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 51

$602K Total Retail Price of All Prescriptions

Rank: 16 out of 51

331 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 331 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

46% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 27%.

Risky Drugs to Seniors

3% of this provider’s 3,739 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 573 126 S3 1 1
BENAZEPRIL HCL 273 99 2 109
HYDROCHLOROTHIAZIDE 204 89 3 15
METFORMIN HCL 176 59 4 9
MELOXICAM 174 66 5 20
BUMETANIDE 173 92 6 127
CEPHALEXIN 172 56 7 67
AMLODIPINE BESYLATE 171 107 8 5
DOXYCYCLINE HYCLATE 155 41 9 90
OMEPRAZOLE 155 70 9 3
PRAVASTATIN SODIUM 152 71 11 19
RANITIDINE HCL 151 58 12 28
LEVOTHYROXINE SODIUM 141 69 13 6
TRAMADOL HCL 126 38 14 10
SUBOXONE 123 11 15 195
SULFAMETHOXAZOLE-TRIMETHOPRIM 117 44 16 62
GABAPENTIN 116 42 17 12
DILTIAZEM HCL 112 33 18 168
ACETAMINOPHEN-CODEINE 112 25 S3 18 96
SIMVASTATIN 97 77 20 4
METOPROLOL TARTRATE 97 60 20 14
POTASSIUM CHLORIDE 97 24 20 8
SYNTHROID 96 74 23 200
CRESTOR 96 42 23 46
NEXIUM 95 29 25 24
NAMENDA 95 80 25 16
ROPINIROLE HCL 95 19 25 75
AMITRIPTYLINE HCL 93 23 R 28 49
CARISOPRODOL 92 0 R 29 116
BACLOFEN 92 20 29 113
CIPROFLOXACIN HCL 92 40 29 48
PROMETHAZINE HCL 90 21 R 32 56
AZITHROMYCIN 84 40 33 47
JANUVIA 82 31 34 108
NAPROXEN 80 19 35 120
CLONIDINE HCL 78 23 36 26
PROPRANOLOL HCL 78 38 36 154
CYCLOBENZAPRINE HCL 77 12 R 38 53
AMPHETAMINE SALT COMBO 77 0 S2 38 266
PROAIR HFA 75 31 40 63
CARVEDILOL 73 24 41 13
AMOXICILLIN 70 28 42 157
HYDROXYZINE HCL 67 18 R 43 99
FENTANYL 66 0 S2 44 65
ZOLPIDEM TARTRATE 65 14 45 22
QUETIAPINE FUMARATE 61 18 46 38
SINGULAIR 60 24 47 95
FLUOXETINE HCL 57 11 48 60
RAMIPRIL 55 32 49 73
ACTOS 54 27 50 138
SYMBICORT 54 30 50 169
BENAZEPRIL-HYDROCHLOROTHIAZIDE 54 18 50 302
CARAFATE 53 24 53 185
IBUPROFEN 52 19 54 93
ATENOLOL 51 17 55 33
ESTRADIOL 51 13 R 55 215
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.